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Prioritisation of research topics for head and neck cancer in Africa – report of the 
International Collaboration On Improving Cancer outcomes in low and middle income 
countries – ICOnIC Africa 
 
Introduction 
Over the past two decades, the burden of cancer in low and middle income countries 
(LMICs) has increased steadily1,2. However many LMICs have limited access to the full array 
of cancer treatments: 70% of developing countries having no access to radiotherapy at all, 
and 98% of patients in low income countries have no access to timely, safe affordable 
surgery3–5. As a result, at least 66% of people diagnosed with cancer in LMICs die from their 
disease, in contrast to less that 50% in high income countries (HICs)6.  The burden of disease 
in LMICs is further heightened by constrained access to allied health services and palliative 
care expertise. In LMICs, where resources are already very stretched, delivery of research, 
addressing the specific problems these countries encounter, is consequently limited. 
 
The International Collaboration On Improving Cancer outcomes in low and middle income 
countries - Africa  (ICOnIC Africa) was established to help identify and develop research to 
address the most pressing research needs in cancer management in Africa.  The 
Collaboration comprises front-line stakeholders in cancer care in Africa, including clinicians, 
patient advocacy groups, training organisations, higher education institutes, and policy 
makers across 14 African countries, along with two universities and professional bodies in 
the UK (Table 1). 
  
 
Head and neck cancer (HNC) in Africa is the first cancer site to be studied by the 
collaboration, as it was deemed to be a good model for a cancer that is relatively common 
in Africa and results in considerable burden to the patient.  It affects all population groups, 
especially those with socioeconomic deprivation, and results in considerable disease burden 
to the patient and is relatively common in Africa. Detailed data are difficult to obtain, as 
many countries’ population level incidence data is not collected or is over a decade old7,8. In 
South Africa, where the data quality is highest, the total incidence of HNC (when including 
all its component subsites) makes it is the 3rd most common cancer in men, and 6th most 
common in women9. The majority of HNC in LMICs present with advanced disease10, and 
due to its anatomical site and treatments, HNC poses one of the highest functional deficits 
of any cancer11; it therefore represents a considerable unmet need in Africa. 
 
To improve cancer management outcomes in Africa, it is important to utilise interventions 
that have been shown to be effective in that setting. To facilitate the generation of this 
evidence, we undertook this study to identify and prioritise the most important research 
questions addressing the areas of greatest unmet need relating to head and neck cancer 




We used a previously published research prioritisation process based on a modified Delphi 
method12; utilising an iterative process that allows consensus on areas of greatest unmet 
need through voting rounds, interspersed with group feedback.  
 
The process comprised of two online voting rounds, each of which was followed by a face to 
face workshop with key stakeholders (figure 1). 
 
Initially, an online survey was established and data collected and managed using the 
Research Electronic Data Capture (REDCap) platform hosted at University of 
Birmingham13,14. REDCap is a secure, web-based software platform designed to support data 
capture for research studies, providing 1) an intuitive interface for validated data capture; 2) 
audit trails for tracking data manipulation and export procedures; 3) automated export 
procedures for seamless data downloads to common statistical packages; and 4) procedures 
for data integration and interoperability with external sources. The survey was composed of 
free text fields and was completed anonymously. It asked participants to give, in their 
opinion, the 3 most pressing issues relating to head and neck cancer management that 
needed research within each of five pre-defined domains: pre-treatment, treatment, post-
treatment, end of life care, and clinical and research training.  Respondents also gave 
information on their role, the type of organisation they worked in, and their country of 
residence. The survey was circulated to the ICOnIC Africa group representatives asking them 
to disseminate the survey via peer to peer networking to ensure the greatest number and 
scope of responders. The survey was open for a period of 4 weeks, from 27th October to 24th 
November 2018, after which responses were collated.  
 
All responses were descriptively assessed, categorised into common themes, and analysed. 
A face to face meeting was held with key stakeholders in Cape Town, South Africa, on 29th 
November to 1st December 2018. The stakeholders included clinicians, patients, patient 
advocacy groups, higher education institutes, hospital managers, social workers, dieticians, 
and policy makers. The meeting reviewed the responses and themes within each domain 
determined from the survey, and the 3 most common themes in each domain were then 
formulated into specific research questions.  
 
The second stage online survey was distributed in the same way as in the first one, and was 
also open for 4 weeks (1st to 29th March 2019). In this round participants were asked to 
order the three priority questions in each of the five domains in order of importance. They 
were also asked to indicate the top three priorities overall from the list of 15.  
 
Following analysis of the data from the second survey, a further workshop was held on 6th-
7th July 2019, in Cape Town, South Africa, attended by a the same key stakeholders. The 
results of the second survey were discussed at this face to face workshop to decide on the 
research topics and to formulate the research studies to be undertaken by the 




Phase 1: Identification of areas of greatest unmet need 
 
A total of 60 individuals from 12 countries completed the first stage survey, covering a wide 
range of roles relating to head and neck cancer, and cancer care as a whole (figure 2). These 
included all types of clinicians involved in cancer care (surgeons, medical and radiation 
oncologists, palliative care physicians), allied healthcare professionals, a patient advocacy 
group, and a policy maker. Most clinician responders worked in urban hospitals with > 200 
beds (76%), and with access to critical care facilities (82%).  
 
The main priority areas identified by the respondents are shown below (table 2). These 
were themed by two members of the steering group independently. The top responses 
were late presentation of disease, poor compliance with follow up, difficulties with access to 
investigations and poor community hospice support. 
 
Phase 2: Workshop 1 
The first workshop reviewed the responses and themes within each domain, and the three 
most common themes in each domain were phrased as specific research questions, which 
were then formulated into an online  survey. The research questions are shown in table 3.  
 
Phase 3: Second round voting 
The second survey was then circulated using the same distribution model. It asked 
respondents to rank each of the 3 research questions within each domain in terms of 
priority. In addition, a final question asked respondents to rank all 15 questions overall in 
terms of importance, regardless of domain.  
 
Thirty nine responders from 8 countries completed the survey, again with a wide range of 
roles relating to head and neck cancer care and patient advocacy. On analysis, the question 
ranked as first within each domain was assigned 5 points, the second 3 points, and the third 
1 point, with a highest attainable score of 195 (if ranked first by each of the 39 responders). 
The highest ranked priorities are shown in table 4.  
 
For overall ranking, the reasons for late presentation scored the highest (being identified as 
one of the top three most important questions overall) by 22 of 39 respondents (56.4%). 
This was followed by improving access to specialist care (17/39, 43.6%), then streamlining 
pathways of investigation and treatment (14/39, 35.9%). 
 
Phase 4: Research planning workshop 
A workshop was held on 6th-7th July 2019, in Cape Town, South Africa, attended by 27 
delegates representing 8 African countries. The results of the prioritisation process were 
presented, and a consensus reached that the initial priority for the Collaborative would be 
to examine reasons for and develop interventions to address late presentation of patients 




Head and neck cancer is an under-represented disease in terms of resource allocation, 
public awareness and research funding in LMICs. The ICOnIC Africa group seeks to help 
address this. As a first step we sought to undertake a research  prioritisation process to 
identify the research areas of greatest need pertaining to head and neck cancer care across 
Africa. A key aim was to involve patients and patient advocacy groups, policy makers, 
evidence synthesis experts, and research and training bodies, as well as clinicians, in Africa 
from the outset, so as to ensure that the outcomes were representative of the setting. 
Identifying and understanding the reasons for late presentation was reported as the area of 
highest priority for those involved in the care of patients with HNC in Africa. 
 
The modified Delphi method has been used to identify research priorities in a number of 
medical fields15, and is one of a number of prioritisation methodologies used 
internationally16,17. We used this process in our study as it allowed for the rapid 
accumulation of data from a geographically disparate group. Whilst we used it for head and 
neck cancer is Africa, this process could be used to potentially assess priorities across other 
countries and regions in the Global South, and for other cancer sites.  
 
Despite wide distribution, many African countries were not represented. This is in part due 
to the lack of engagement in healthcare research in some countries, often due to the heavy 
workload of clinicians being such that no time or resources are available to engage in any 
other activity than direct patient care18.  
 
Late presentation is not unique to HNC in LMICs. Research has been undertaken to examine 
factors that contribute to the late presentation of other malignancies, including breast, 
cervical and oesophageal cancer19–22. However, little work has been done in HNC, which has 
and additional set of challenges, relating to loss of function and stigma from visible 
disfigurement, that may also contribute to late presentation. 
 
The priorities ranked second and third overall are also components of the “pre-treatment” 
domain, and this is again a common theme amongst studies identifying ways in which 
cancer care can be improved in LMICs. Indeed, improving access to specialist care as well as 
streamlining pathways of investigation may itself contribute to reducing late presentation 
amongst patients with HNC.  
 
The next work stream of the ICOnIC programme will be to identify, through systematic 
reviews, qualitative research and stakeholder engagement, the factors that contribute to 
late presentation, and to then develop interventions to address these.  
Tables 
 
African Head and Neck Society 
African Cancer Institute 
African Organisation for Research and Training in 
Cancer (AORTIC) 
African Palliative Care Association 
British Association of Head and Neck Oncologists 
(BAHNO)^ 
Cancer Alliance* 
Cancer Research Initiative 
Cancer Heroes* 
CANSA* 
Chronic Disease Initiative for Africa 
Cochrane Africa 
Egyptian Society of Head and Neck Oncology 
Ghana Health Service 
Jembi Health Systems 
Kings College London^ 
South African Medical Research Council 
Stellenbosch University 
University of Birmingham^ 
University of Cape Town 
Table 1: ICOnIC Africa Collaboration (*patient group, ^ UK group) 
 
 




 Patient awareness of symptoms (21) 
 Clinician awareness of symptoms (10) 
 Late presentation/lack of early diagnosis (31) 
 Pre-treatment optimization (11) 
 Availability of histopathology (5) 
 Problems with the stigma of cancer (9) 
 Poor access to care (7) 
 Pathways not obvious (9) 
 Access to investigations (26) 
Treatment  Lack of resources (40) 
 Cost of treatment (20) 
 Non-compliance with treatment (8) 
 Psychosocial support to complete treatment (8) 
 Controversies in histopathology reporting (2) 
 Speech rehabilitation (7) 
 Influence of comorbidities (4) 
 Difficult to follow international guidelines (8) 
 Recovery and rehabilitation after surgery (3) 
Post-
treatment care 
and follow up 
 Poor community based support (6) 
 Difficulty making follow up/poor compliance with follow up (28) 
 Poor CNS support (9) 
 Poor support for side effects of treatment (13) 
 Ongoing rehabilitation (11) 
 No survivorship program (10) 
 Difficult to pick up early recurrence (13) 
End of life care  Limited palliative care services available (21) 
 Lack of awareness of importance of palliative care as part of MDT (4) 
 Community hospice support lacking (26) 
 Unable to manage patients at home (14) 
 Psychosocial/spiritual support availability (12) 
 Cost of end of life drugs (11) 
 Cultural differences in attitude to death (7) 




 Limited funds for research/difficult to access research funding (21) 
 Support with grant writing (6) 
 Training in research methodology (19) 
 Funding for collaborators (3) 
 Clinical staff already over-loaded with work (9) 
 Clinical guidelines needed along the care pathway (3) 
 Data quality improvement (2) 
Table 2: Themed responses from the first round survey (number of responses received for 
each theme in brackets) 
 
 
Pre-treatment care and pathways 
• What are the reasons for late presentation amongst head and neck cancer patients, 
and how can this be improved? 
• How can pathways of investigation and treatment be improved to streamline care? 
• How can resources be optimised to improve access to specialist treatment? 
Treatment 
• What are the barriers to accepting and complying with treatment? 
• How can the histopathological reporting of specimens be improved, made more 
timely and made more standardised across all regions? 
• What low cost interventions could be made to significantly improve outcomes of 
treatment? 
Post-treatment care and follow up 
• What are the reasons for poor compliance with follow up and for late detection of 
recurrence? 
• How can community support be maximised to facilitate earlier discharge from 
hospital? 
• How could effective survivorship programmes reduce the stigma associated with a 
diagnosis of cancer? 
End of life care 
• How can pathways, training and resourcing be improved to allow greater access to 
palliative care? 
• What are the best interventions for end of life care in low resource settings? 
• What are the barriers to people receiving end of life care, and how is it best to 
address them? 
Clinical and research training 
• How can a culture of research be fostered and maintained on a local, national, and 
international level? 
• What are the barriers to effective research training? 
• What are the best designs and methodologies for delivering effective clinical 
research in low cost settings? 
Table 3: Research questions developed following steering group workshop. 
 
 
Pre-treatment care and pathways:  
What are the reasons for late presentation amongst head and neck cancer patients, and 
how can this be improved? (135) 
Treatment:  
What low cost interventions could be made to significantly improve outcomes of 
treatment? (124) 
Post-treatment care and follow up:  
What are the reasons for poor compliance with follow up and for late detection of 
recurrence? (163) 
End of life care:  
What are the best interventions for end of life care in low resource settings? (103) 
Clinical and research training:  
What are the best designs and methodologies for delivering effective clinical research in 
low cost settings? (123) 








Figure 1: Overview of prioritisation process 
 
Phase 1: Identification of areas of greatest unmet need
Online REDCap survey distributed to participants in African 
countries to identify research areas – free text response
Phase 2: Steering group workshop
Face to face meeting in South Africa to develop research 
questions to be put to vote
Phase 3: Second round voting
Online REDCap survey distributed to participants in African 
countries to vote and rank research questions
Phase 4: Research planning workshop
Face to face workshop in South Africa to discuss results and 
develop further research strategy 
 
Figure 2: A – Country of residence of respondents and B - Role of respondents in phase 1 
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